Norepinephrine Bitartrate Injection USP 4 mg/4 mL
Lack of Assurance of Sterility
1,058 recalls, newest first
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Complaint received of foreign matter (metal) embedded in tablet.
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Superpotent and Failed Tablet/Capsule Specifications
Failed Impurities/Degradation Specifications
Out-of-specification impurity test result observed at 18-month long term stability time point.
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Defective Delivery System
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Microbial Contamination of Non-Sterile Product
Failed impurities/degradation specifications
Failed Dissolution Specifications
Subpotent
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.
Defective Container: Leaking containers.
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations
CGMP Deviations